The family of Elder Pharma founder Jagdish Saxena, who died in 2013, has been embroiled in a bitter battle for control of his personal & bu...

Elder Pharma today said its nutraceutical product Eldervit is set to become Rs 100 crore brand by the end of financial year 2016 and a Rs 3...

Elder Pharmaceuticals has defaulted on interest payment of Rs 261.8 crore on its debentures.

Elder Pharmaceuticals today said it has elevated Alok Saxena as the Managing Director and Chief Executive Officer of the company.

Sanofi, Novartis and GSK are in the race to buy out the domestic formulations business of debt-ridden Elder Pharmaceuticals.

Elder Pharmaceuticals will be investing Rs 15-20 crore over the next two-three years for its foray into cosmetics manufacturing.

Elder Pharmaceuticals today said it has formed a joint venture with Japan's Kose Corporation to manufacture and sell cosmetics in India.

UP minister Abhishek Mishra says job market opening up.. Asks industry and students to engage with each other to explore opportunities.

Elder Pharma today said its consolidated net profit rose by 22 per cent to Rs 23.60 crore in the July-September quarter.

Nutraceuticals is another area where the company is expanding its operations, catering to cardiac, diabetic and kidney disease patients, Sa...

In an interview with ET Now, Alok Saxena, Jt. MD, Elder Pharma, talks about the pharmaceutical sector and its market. Excerpts:

Elder Pharmaceuticals today said its shareholders have approved a final dividend of 30 per cent for the financial year ended March 31, 2011.

In a chat with ET Now, Alok Saxena, Joint Managing Director, Elder Pharmaceuticals Limited, shares his views on company's performance.

The R&D centre has recently been modernised and expanded and now consists of about 100 scientists.

Indian drug maker Elder Pharmaceuticals plans to enter the nicotine replacement therapy, or anti-smoking segment, with chewable jelly cubes...

Italian pharma company Angellini Acraf has hiked its stake in Elder Pharma. The company, which already holds around 10% stake in Elder Phar...

Betting big on the African market, Elder Pharmaceuticals is planning to set up a joint venture company in Ghana and expects to have footpri...